University of Washington

Health Systems and Population Health

SCHOOL OF PUBLIC HEALTH

Revisiting the cost-effectiveness of omalizumab.


  1. Home


  2. Revisiting the cost-effectiveness of omalizumab.


  3. Revisiting the cost-effectiveness of omalizumab.

rakerr2

Campbell JD, Spackman DE, Sullivan SD. Revisiting the cost-effectiveness of omalizumab. Allergy. 2007 Dec;62(12):1469.

Upcoming Events

Full Calendar

News Categories